How effective is natalizumab induction therapy in patients with Crohns disease?
Original article Targan SR et al. (2007) Natalizumab for the treatment of active Crohn’s disease: results of the ENCORE trial. Gastroenterology 132: 1672–1683 PubMedNatalizumab might be an effective induction therapy for patients with moderately to severely active Crohn’s disease and active inflammation.